Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Viral targeting of non-muscle invasive bladder cancer and priming of anti-tumour immunity following intravesical Coxsackievirus A21.

Annels NE, Mansfield D, Arif M, Ballesteros-Merino C, Simpson GR, Denyer M, Sandhu SS, Melcher A, Harrington KJ, Davies B, Au G, Grose M, Bagwan IN, Fox BA, Vile RG, Mostafid H, Shafren D, Pandha H.

Clin Cancer Res. 2019 Jul 4. pii: clincanres.4022.2018. doi: 10.1158/1078-0432.CCR-18-4022. [Epub ahead of print]

PMID:
31273010
2.

Membrane insertion and secretion of the Engrailed-2 (EN2) transcription factor by prostate cancer cells may induce antiviral activity in the stroma.

Punia N, Primon M, Simpson GR, Pandha HS, Morgan R.

Sci Rep. 2019 Mar 26;9(1):5138. doi: 10.1038/s41598-019-41678-0.

3.

Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus.

Annels NE, Arif M, Simpson GR, Denyer M, Moller-Levet C, Mansfield D, Butler R, Shafren D, Au G, Knowles M, Harrington K, Vile R, Melcher A, Pandha H.

Mol Ther Oncolytics. 2018 Feb 14;9:1-12. doi: 10.1016/j.omto.2018.02.001. eCollection 2018 Jun 29.

4.

Synergistic antitumour effects of rapamycin and oncolytic reovirus.

Comins C, Simpson GR, Rogers W, Relph K, Harrington K, Melcher A, Roulstone V, Kyula J, Pandha H.

Cancer Gene Ther. 2018 Jun;25(5-6):148-160. doi: 10.1038/s41417-018-0011-8. Epub 2018 May 3.

PMID:
29720674
5.

Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells.

Alharbi RA, Pandha HS, Simpson GR, Pettengell R, Poterlowicz K, Thompson A, Harrington K, El-Tanani M, Morgan R.

Oncotarget. 2017 Aug 7;8(52):89566-89579. doi: 10.18632/oncotarget.20023. eCollection 2017 Oct 27.

6.

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances.

Simpson GR, Relph K, Harrington K, Melcher A, Pandha H.

Oncolytic Virother. 2016 Jan 6;5:1-13. doi: 10.2147/OV.S66083. eCollection 2016. Review.

7.

Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer.

Annels NE, Simpson GR, Denyer M, McGrath SE, Falgari G, Killick E, Eeles R, Stebbing J, Pchejetski D, Cutress R, Murray N, Michael A, Pandha H.

Clin Exp Immunol. 2014 Aug;177(2):428-38. doi: 10.1111/cei.12332.

8.

Targeting HOX transcription factors in prostate cancer.

Morgan R, Boxall A, Harrington KJ, Simpson GR, Michael A, Pandha HS.

BMC Urol. 2014 Feb 5;14:17. doi: 10.1186/1471-2490-14-17.

9.

Targeting the HOX/PBX dimer in breast cancer.

Morgan R, Boxall A, Harrington KJ, Simpson GR, Gillett C, Michael A, Pandha HS.

Breast Cancer Res Treat. 2012 Nov;136(2):389-98. doi: 10.1007/s10549-012-2259-2. Epub 2012 Sep 30.

PMID:
23053648
10.

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer.

Simpson GR, Horvath A, Annels NE, Pencavel T, Metcalf S, Seth R, Peschard P, Price T, Coffin RS, Mostafid H, Melcher AA, Harrington KJ, Pandha HS.

Br J Cancer. 2012 Jan 31;106(3):496-507. doi: 10.1038/bjc.2011.577. Epub 2012 Jan 12.

11.

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer.

Heinemann L, Simpson GR, Boxall A, Kottke T, Relph KL, Vile R, Melcher A, Prestwich R, Harrington KJ, Morgan R, Pandha HS.

BMC Cancer. 2011 Jun 6;11:221. doi: 10.1186/1471-2407-11-221.

12.

The effect of cell cycle synchronization on tumor sensitivity to reovirus oncolysis.

Heinemann L, Simpson GR, Annels NE, Vile R, Melcher A, Prestwich R, Harrington KJ, Pandha HS.

Mol Ther. 2010 Dec;18(12):2085-93. doi: 10.1038/mt.2010.189. Epub 2010 Sep 14.

13.

Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo.

Anesti AM, Simpson GR, Price T, Pandha HS, Coffin RS.

BMC Cancer. 2010 Sep 13;10:486. doi: 10.1186/1471-2407-10-486.

14.

Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma.

Pandha HS, Heinemann L, Simpson GR, Melcher A, Prestwich R, Errington F, Coffey M, Harrington KJ, Morgan R.

Clin Cancer Res. 2009 Oct 1;15(19):6158-66. doi: 10.1158/1078-0432.CCR-09-0796. Epub 2009 Sep 22.

15.
16.

Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control.

Simpson GR, Han Z, Liu B, Wang Y, Campbell G, Coffin RS.

Cancer Res. 2006 May 1;66(9):4835-42.

17.

Morphine preexposure facilitates morphine place preference and attenuates morphine taste aversion.

Simpson GR, Riley AL.

Pharmacol Biochem Behav. 2005 Mar;80(3):471-9.

PMID:
15740790
18.

Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions.

Mattsson K, Kiss C, Platt GM, Simpson GR, Kashuba E, Klein G, Schulz TF, Szekely L.

J Gen Virol. 2002 Jan;83(Pt 1):179-88.

PMID:
11752715
19.

Assessment of SNC 80 and naltrindole within a conditioned taste aversion design.

Hutchinson AC, Simpson GR, Randall JF, Zhang X, Calderon SN, Rice KC, Riley AL.

Pharmacol Biochem Behav. 2000 Aug;66(4):779-87.

PMID:
10973516
21.

Cocaine preexposure fails to sensitize the acquisition of cocaine-induced taste aversions.

Riley AL, Simpson GR.

Pharmacol Biochem Behav. 1999 Jun;63(2):193-9.

PMID:
10371647
22.

Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy.

Calabrò ML, Sheldon J, Favero A, Simpson GR, Fiore JR, Gomes E, Angarano G, Chieco-Bianchi L, Schulz TF.

J Hum Virol. 1998 Mar-Apr;1(3):207-13.

PMID:
10195244
23.

Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.

Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J.

AIDS. 1998 Dec 24;12(18):2481-8.

PMID:
9875587
24.

Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.

Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, Ebbesen P, Schulz TF.

Int J Cancer. 1998 Aug 12;77(4):543-8.

25.

Chlordiazepoxide-induced conditioned place and taste aversion learning in rats.

Parker LA, Limebeer CL, Simpson GR.

Pharmacol Biochem Behav. 1998 Jan;59(1):33-7.

PMID:
9443533
26.
27.

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.

Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS.

Lancet. 1996 Oct 26;348(9035):1133-8.

PMID:
8888167
28.

Endogenous D-type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcriptase.

Simpson GR, Patience C, Löwer R, Tönjes RR, Moore HD, Weiss RA, Boyd MT.

Virology. 1996 Aug 15;222(2):451-6.

29.

Human endogenous retrovirus expression and reverse transcriptase activity in the T47D mammary carcinoma cell line.

Patience C, Simpson GR, Colletta AA, Welch HM, Weiss RA, Boyd MT.

J Virol. 1996 Apr;70(4):2654-7.

30.
31.

Computers in practice.

Simpson GR.

Med J Aust. 1979 Aug 25;2(4):198-9. No abstract available.

PMID:
514131
32.

The computer in general medical practice.

Simpson GR.

Aust Fam Physician. 1979 Apr;8(4):437-40, 442-3. No abstract available.

PMID:
454316
33.

Exposure of council and forestry workers to 2,4,5-T.

Simpson GR, Higgins V, Chapman J, Bermingham S.

Med J Aust. 1978 Nov 18;2(11):536-7.

PMID:
732649
34.

Poisoning by carbamate pesticides.

Simpson GR, Bermingham S.

Med J Aust. 1977 Jul 30;2(5):148-9.

PMID:
895649
35.

Variations of pulmonary function amongst workers in cotton mills.

Barnes R, Simpson GR.

J Occup Med. 1976 Aug;18(8):551-5.

PMID:
956940
36.

Use and health effects of Aroclor 1242, a polychlorinated biphenyl, in an electrical industry.

Ouw HK, Simpson GR, Siyali DS.

Arch Environ Health. 1976 Jul-Aug;31(4):189-94.

PMID:
821401
37.

An unusual presentation of systemic organophosphate poisoning.

Bisby JA, Simpson GR.

Med J Aust. 1975 Sep 6;2(10):394-5.

PMID:
127108
38.
39.

Pesticide poisonings in the Namoi and Macquarie Valleys, 1973.

Simpson GR, Penney DJ.

Med J Aust. 1974 Feb 23;1(8):258-60. No abstract available.

PMID:
4821536
40.
41.

Exposure to chlorinated hydrocarbon pesticides by pest control operators.

Simpson GR, Shandar A.

Med J Aust. 1972 Nov 4;2(19):1060-3. No abstract available.

PMID:
4642421
42.

A byssinosis survey.

Barnes R, Simpson GR.

Med J Aust. 1972 Jul 29;2(5):238-42. No abstract available.

PMID:
5075993
43.
44.

A note on cotton dust and proteolytic enzymes: recent developments.

Simpson GR.

Med J Aust. 1972 Apr 1;1(14):717. No abstract available.

PMID:
5029996
45.

The dangers of proteolytic enzymes to workers.

Simson RE, Simpson GR.

Med J Aust. 1971 Jun 5;1(23):1242-3. No abstract available.

PMID:
4254876
46.

Fatal hydrogen sulphide poisoning associated with industrial waste exposure.

Simson RE, Simpson GR.

Med J Aust. 1971 Feb 6;1(6):331-4. No abstract available.

PMID:
5546220
47.

Exposure to dust in the cotton-garnetting industry.

Simpson GR.

Med J Aust. 1970 Jun 6;1(23):1151-2. No abstract available.

PMID:
5270383
48.

Poisoning with monocrotophos, an organophosphorus pesticide.

Simson RE, Simpson GR, Penney DJ.

Med J Aust. 1969 Nov 15;2(20):1013-6. No abstract available.

PMID:
5373217
49.

Cotton dust exposure during lint removal. Airborne dust concentrations and effect of the ventilatory capacity of exposed workers.

Simpson GR, Barnes R.

Arch Environ Health. 1968 Nov;17(5):807-10. No abstract available.

PMID:
5696041
50.

Ventilatory capacity changes on exposure to cotton dust.

Barnes R, Simpson GR.

Med J Aust. 1968 May 25;1(21):897-900. No abstract available.

PMID:
5690195

Supplemental Content

Loading ...
Support Center